Indication · Cardiology
High blood pressure (hypertension)
Last checked: Nov 19, 2026Source: FDA, ClinicalTrials.gov
Devices
710
Cleared or approved since 2000
PMA and De Novo
18
Higher-risk or first-of-kind devices
Breakthrough devices
3
Authorized through June 30, 2026
Recruiting device trials
241
1,914 device trials in all
Breakthrough-designated devices
- Symplicity Spyral Renal Denervation SystemMedtronic, Inc. · 2026
- Paradise Ultrasound Renal Denervation System (Paradise System)Recor Medical, Inc. · 2026
- BAROSTIM NEO® SystemCvrx, Inc. · 2023
Devices
710 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Barostim System
Cvrx, Inc. · PMA · Stimulator, Carotid Sinus Nerve · newest 2023 · 5 decisions
- BAROSTIM NEO® System
Cvrx, Inc. · PMA · Stimulator, Carotid Sinus Nerve · newest 2023 · 4 decisions
- Formula Balloon-Expandable Renal Stent System
Cook Medical Incorporated · PMA · Stent, Renal · newest 2014 · 4 decisions
57 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)Completed
Sight Sciences, Inc.Not on our public-company list
NCT06948773 · 25 participants · Start May 21, 2025 · Primary completion Sep 7, 2026
Device: Helix Surgical System · For: Primary Open Angle Glaucoma; Cataract
Sites: Panama City, Panama
Shape Medical Systems, Inc.Not on our public-company list
NCT05977933 · 0 participants · Start Sep 25, 2024 · Primary completion Sep 25, 2024
Device: Shape II CPET · For: Pulmonary Arterial Hypertension
Sites: Torrance, California; Denver, Colorado; Jascksonville, Florida · 6 sites in all
- Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)Terminated
Gossamer Bio USA, Inc.Not on our public-company list
NCT04816604 · 74 participants · Start Apr 5, 2021 · Primary completion Sep 9, 2026
Device: Generic Dry Powder Inhaler · For: Pulmonary Arterial Hypertension
Sites: Sacramento, California; Santa Barbara, California; Jacksonville, Florida · 28 sites in all
1,911 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- System, Measurement, Blood-Pressure, Non-Invasive (DXN)579
- Blood Pressure Cuff (DXQ)103
- Stent, Renal (NIN)11
- Radioimmunoassay, Angiotensin I And Renin (CIB)5
- Ablation Catheter, Renal Denervation (QYI)5
- Radioimmunoassay, Aldosterone (CJM)3
- Stimulator, Carotid Sinus Nerve (DSR)2
- Reprocessed Blood Pressure Cuff (NPP)1
- Hypertension Machine Learning-Based Notification Software (SFR)1
Research
- Device studies on hypertension across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.